Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu-Hsien Yu

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Biomedicines|August 27, 2021
Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated AnalysisKuo-Min Su, Hong-Wei Gao, Chia-Ming Chang, et al.
The Journal of Pathology|August 1, 2009
Characterization of LMX-1A as a metastasis suppressor in cervical cancerChin-Yu Liu, Tai-Kuang Chao, Po-Hsuan Su, et al.
Gynecologic Oncology|December 20, 2008
SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathwayMing-Tzeung Chung, Hung-Cheng Lai, Huey-Kang Sytwu, et al.
Scientific Reports|January 13, 2021
Integration of genome-wide association study and expression quantitative trait locus mapping for identification of endometriosis-associated genesYa-Ching Chou, Ming-Jer Chen, Pi-Hua Chen, et al.
The Journal of Obstetrics and Gynaecology Research|May 27, 2016
Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinomaLi-Chun Liu, Hung-Cheng Lai, Yu-Ching Chou, et al.
Journal of Gynecologic Oncology|January 25, 2013
Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology GroupYu-Li Chen, Kung-Liahng Wang, Min-Yu Chen, et al.
International Journal of Cancer|December 4, 2009
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathwayHer-Young Su, Hung-Cheng Lai, Ya-Wen Lin, et al.
BMC Cancer|May 20, 2015
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmCheng-Chang Chang, Rui-Lan Huang, Yu-Ping Liao, et al.
Gynecologic Oncology|July 21, 2004
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced diseaseChih-Ming Ho, Yun-Ju Huang, Tze-Chien Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2010
Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinomaChih-Ming Ho, Wen-Fang Cheng, Ming-Chieh Lin, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Biomedicines|August 27, 2021
Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated AnalysisKuo-Min Su, Hong-Wei Gao, Chia-Ming Chang, et al.
The Journal of Pathology|August 1, 2009
Characterization of LMX-1A as a metastasis suppressor in cervical cancerChin-Yu Liu, Tai-Kuang Chao, Po-Hsuan Su, et al.
Gynecologic Oncology|December 20, 2008
SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathwayMing-Tzeung Chung, Hung-Cheng Lai, Huey-Kang Sytwu, et al.
Scientific Reports|January 13, 2021
Integration of genome-wide association study and expression quantitative trait locus mapping for identification of endometriosis-associated genesYa-Ching Chou, Ming-Jer Chen, Pi-Hua Chen, et al.
The Journal of Obstetrics and Gynaecology Research|May 27, 2016
Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinomaLi-Chun Liu, Hung-Cheng Lai, Yu-Ching Chou, et al.
Journal of Gynecologic Oncology|January 25, 2013
Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology GroupYu-Li Chen, Kung-Liahng Wang, Min-Yu Chen, et al.
International Journal of Cancer|December 4, 2009
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathwayHer-Young Su, Hung-Cheng Lai, Ya-Wen Lin, et al.
BMC Cancer|May 20, 2015
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmCheng-Chang Chang, Rui-Lan Huang, Yu-Ping Liao, et al.
Gynecologic Oncology|July 21, 2004
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced diseaseChih-Ming Ho, Yun-Ju Huang, Tze-Chien Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2010
Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinomaChih-Ming Ho, Wen-Fang Cheng, Ming-Chieh Lin, et al.
Pageof 11